A Synthetic Peptide Destroys Brain Plaque Implicated in Alzheimer's Disease

New York, NY- June 29, 1998-- New York University School of Medicine researchers have created a protein fragment that blocks the formation of a substance implicated in causing Alzheimer's disease, a finding that may lay the foundation for a novel therapy for the mind robbing disease.

Alzheimer's disease is characterized by the destruction of nerve cells, especially in the areas of the brain vital to memory and learning. A key question is what causes the loss of the cells. As yet, scientists don't know the answer. Round plaques composed of a protein called amyloid are one of the hallmarks of Alzheimer's disease and increasing evidence suggests that amyloid causes the death of nerve cells.

In a new study, led by Claudio Soto, Ph.D., Research Assistant Professor of Neurology and Pathology at NYU School of Medicine, a custom-designed sequence of just five amino acids completely blocked the formation of amyloid in the brains of rats, destroyed already existing amyloid and prevented the death of nerve cells caused by amyloid in tissue cultures of human nerve cells. The findings are published in the July issue of the journal Nature Medicine.

"Whether or not amyloid formation directly causes Alzheimer's disease, it is a good target for therapy," says Dr. Soto. "We think that these findings open the way for a new therapeutic approach to treating Alzheimer's disease by preventing the deposition of senile plaques," says Dr. Soto. "We also believe that our compound may be useful in treating other diseases caused by defective protein folding, including prion disease and amyotrophic lateral sclerosis or Lou Gehrig's disease."

Amino acids hook together to form peptides and proteins. Amyloid plaque is deposited in the brain as sheets, explains Dr. Soto. These sheets, which may contain thousands of protein strings, form a shape called "beta-pleated." In order to continue forming the pleated sheets, the strings must be folded in a particular way

Contact: Marjorie Shaffer
New York University Medical Center and School of Medicine

Page: 1 2

Related biology news :

1. Synthetic hormone used in contraceptives and HRT produces negative effects in monkey studies
2. Synthetic antifreeze could prevent ice growth
3. Synthetic clay could assist radioactive waste cleanup
4. New Class Of Synthetic Capsules That Mimic Biological Cells Has Wide Array Of Potential Uses
5. Synthetic Lock Binds Some Molecules, Excludes Others
6. Cellular Engineers Design Custom Cell Surfaces Able To Adhere To Synthetic Materials
7. Synthetic Vitamin E And Natural Vitamin E Are Equally Powerful Antioxidents
8. Peptide suppresses multiple sclerosis-like disease
9. Key Peptides Found That Stop -- Even Reverse -- Kidney Disease In Lupus
10. Peptides Implicated In Bodys Response To Pain
11. New Anti-Microbial Agent Destroys Anthrax

Post Your Comments:

(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... In its ... feature interview with Dr. James L. Sherley, M.D., Ph.D., founder and director of ... the company announced on June 16 that starting July 5 it would ...
(Date:6/11/2020)... ... June 08, 2020 , ... ... and other protective measures to protect workers in the medical field. The face ... staffs who valiantly risk their lives every day to provide healthcare to pregnant ...
(Date:6/2/2020)... MILWAUKEE (PRWEB) , ... June ... ... International, the world’s leading barcode and RFID labeling software developer and solutions ... TEKLYNX CENTRAL , improved labeling accuracy and compliance by 100%, resulting ...
Breaking Biology News(10 mins):
(Date:6/3/2020)... MONTREAL (PRWEB) , ... June 03, 2020 , ... ... designed to highlight various applications of biofeedback. In the next installment, Dr. Inna ... a practice whereby individuals learn to bring their attention to the feelings, thoughts, ...
(Date:5/30/2020)... ... 29, 2020 , ... Medrio, Inc., the leading provider of ... enabled Cytovale, Inc., a medical technology company dedicated to revolutionizing diagnostics for conditions ... patient in (FPI) in just seven days. The Cytovale technology will allow patients ...
(Date:5/28/2020)... (PRWEB) , ... May 28, 2020 , ... ... R&D, today announced the release of Genedata Screener ® 17.0, the latest ... screening data from all in-vitro screening assay technologies. Genedata will host a webinar ...
(Date:5/26/2020)... ... May 26, 2020 , ... Brilliant , the leading smart ... smart garage door openers, announce a new integration to bring more convenience, simplicity, and ... openers powered by Aladdin Connect® can now be controlled from Brilliant’s in-wall touchscreen control ...
Breaking Biology Technology:
Cached News: